Antioxidant inflammation modulators: novel derivatives of oleanolic acid
Disclosed herein are novel oleanolic acid derivatives. Methods of preparing these compounds are also disclosed. The oleanolic acid derivatives of this invention may be used for the treatment and prevention of many diseases, including cancer, neurological disorders, inflammation, and pathologies involving oxidative stress.
1. A compound of the formula:
wherein:
R a is azido, fluoro, hydroxyamino, alkoxyamino (C≦12) , substituted alkoxyamino (C≦12) , or —NH-L-R d ;
wherein:
L is alkanediyl (C≦8) ; and
R d is:
hydroxy; or
alkoxy (C≦18) , aryloxy (C≦18) , or acyloxy (C≦18) , or a substituted version of any of these groups;
R 1 is:
hydrogen, cyano, hydroxy, halo or amino; or
alkyl (C≦8) , alkenyl (C≦8) , alkynyl (C≦8) , aryl (C≦8) , aralkyl (C≦8) , heteroaryl (C≦8) , heteroaralkyl (C≦8) , acyl (C≦8) , alkoxy (C≦8) , aryloxy (C≦8) , acyloxy (C≦8) , alkylamino (C≦8) , arylamino (C≦8) , amido (C≦8) , or a substituted version of any of these groups;
R 4 and R 5 are each independently alkyl (C≦18) or substituted alkyl (C≦18) ;
R 6 is hydrogen, hydroxy or oxo; and
or a pharmaceutically acceptable salt, tautomer, or optical isomer thereof.
2. The compound according to claim 1 , further defined as:
wherein R a is azido, fluoro, hydroxyamino, alkoxyamino (C≦12) or substituted alkoxyamino (C≦12) ;
or a pharmaceutically acceptable salt, tautomer, or optical isomer thereof.
3. The compound of claim 1 , wherein R 4 and R 5 are each methyl.
4. The compound of claim 1 , wherein one of R 4 and R 5 is hydroxymethyl and the other is methyl.
5. The compound of claim 1 , wherein R 6 is hydrogen.
6. The compound of claim 1 , wherein R 6 is hydroxy.
7. The compound of claim 1 , wherein R 6 is oxo.
8. The compound of claim 1 , further defined as:
9. The compound of structure: